Related references
Note: Only part of the references are listed.Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
Emmanuelle Boffi El Amari et al.
AIDS (2009)
African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study
Viktor Mueller et al.
AIDS (2009)
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection
Sabine Yerly et al.
AIDS (2009)
Long-Term Trends of HIV Type 1 Drug Resistance Prevalence among Antiretroviral Treatment-Experienced Patients in Switzerland
Viktor von Wyl et al.
CLINICAL INFECTIOUS DISEASES (2009)
Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV-Infected Patients
Olivia Veit et al.
CLINICAL INFECTIOUS DISEASES (2009)
Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals
M. Arab-Alameddine et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study
C. Bellini et al.
HIV MEDICINE (2009)
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study
R. Weber et al.
HIV MEDICINE (2009)
JC Virus-Specific Immune Responses in Human Immunodeficiency Virus Type 1 Patients with Progressive Multifocal Leukoencephalopathy
Nina Khanna et al.
JOURNAL OF VIROLOGY (2009)
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis
Ravindra K. Gupta et al.
LANCET INFECTIOUS DISEASES (2009)
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
Jerry Polesel et al.
AIDS (2008)
Does short-term virologic failure translate to clinical events in antiretroviral-naive patients initiating antiretroviral therapy in clinical practice? The Antiretroviral Therapy Cohort Collaboration (ART-CC)
Michael J. Mugavero et al.
AIDS (2008)
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study
Philippe Brossard et al.
AIDS (2008)
The effect of antiretroviral treatment of different durations in primary HIV infection
Nikos Pantazis et al.
AIDS (2008)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients
Jens D. Lundgren et al.
AIDS (2008)
Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection
Jorge Garbino et al.
AIDS (2008)
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
A. d'Arminio Monforte et al.
AIDS (2008)
HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy
Barbara Weiser et al.
AIDS (2008)
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
Gary M. Clifford et al.
AIDS (2008)
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
S. Franceschi et al.
BRITISH JOURNAL OF CANCER (2008)
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
Nina Khanna et al.
CLINICAL INFECTIOUS DISEASES (2008)
HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy
Andri Rauch et al.
CLINICAL INFECTIOUS DISEASES (2008)
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction
C. A. Sabin et al.
CLINICAL INFECTIOUS DISEASES (2008)
Antiretroviral drug resistance testing in adult HIV-1 infection:: 2008 recommendations of an International AIDS Society-USA panel
Martin S. Hirsch et al.
CLINICAL INFECTIOUS DISEASES (2008)
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination Antiretroviral therapy containing tenofovir
Viktor von Wyl et al.
CLINICAL INFECTIOUS DISEASES (2008)
High prevalence of peripheral arterial disease in HIV-infected persons
Daniel Periard et al.
CLINICAL INFECTIOUS DISEASES (2008)
Incidence and risk factors for new-onset diabetes, in HIV-infected patients -: The data collection on adverse events of Anti-HIV drugs (D:A:D) study
Stephane De Wit et al.
DIABETES CARE (2008)
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study
M. Wolbers et al.
HIV MEDICINE (2008)
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study
D. M. Wunder et al.
HIV MEDICINE (2008)
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006
A. Nguyen et al.
HIV MEDICINE (2008)
Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays:: Results from an international collaboration on HIV-2 infection in 2006
Florence Damond et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults
David Dunn et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Durability and outcome of initial antiretroviral treatments received during 2000-2005 by patients in the Swiss HIV Cohort Study
Thi Tuyet Nhung Vo et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The HCP5 single-nucleotide polymorphism:: A simple screening tool for prediction of hypersensitivity reaction to abacavir
Sara Colombo et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study:: a multi-cohort collaboration
Caroline A. Sabin et al.
LANCET (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children
Christoph Rudin et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
HIV rebounds from latently infected cells, rather than from continuing low-level replication
Beda Joos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort
Patrick Taffe et al.
STATISTICS IN MEDICINE (2008)
Public-health and individual approaches to antiretroviral therapy: Township South Africa and Switzerland compared
Olivia Keiser et al.
PLOS MEDICINE (2008)
Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy -: Collaborative analysis of cohorts of HIV-1-Infected patients
Jonathan A. C. Sterne et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries
Martin W. G. Brinkhof et al.
CLINICAL INFECTIOUS DISEASES (2007)
Sudden infant death syndrome in infants born to HIV-infected and opiate-using mothers
Christian Kahlert et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2007)
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Marcel Wolbers et al.
AIDS (2007)
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients
Francesca Ceccherini-Silberstein et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7
Margalida Rotger et al.
PHARMACOGENETICS AND GENOMICS (2007)
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score
Amanda Mocroft et al.
AIDS (2007)
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination Antiretroviral treatment -: A comparison of different regimen types
Viktor Von Wyl et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes
Philipp Kaiser et al.
JOURNAL OF VIROLOGY (2007)
A whole-genome association study of major determinants for host control of HIV-1
Jacques Fellay et al.
SCIENCE (2007)
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
A. Mocroft et al.
LANCET (2007)
Increased Epstein-Barr virus-specific antibody-level nervous system lymphoma
Olivier Gasser et al.
AIDS (2007)
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the swiss HIV cohort study
Bruno Ledergerber et al.
CLINICAL INFECTIOUS DISEASES (2007)
The role of compartment penetration in PI-monotherapy: the atazanavir-ritonavir monomaintenance (ATARITMO) trial
Pietro Vernazza et al.
AIDS (2007)
When time is more than money: The allocation of time between work and leisure in HIV-infected patients
Pedram Sendi et al.
SOCIAL SCIENCE & MEDICINE (2007)
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
Maureen P. Martin et al.
NATURE GENETICS (2007)
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression
A. J. Frater et al.
JOURNAL OF VIROLOGY (2007)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals
M. Rotger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts
Olivier Gasser et al.
PLOS MEDICINE (2007)
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Tracy R. Glass et al.
HIV CLINICAL TRIALS (2007)
Two versus three-class antiretroviral therapy in anti retroviral-naive patients in different time periods of the HAART era
Patrick Taffe et al.
AIDS (2007)
Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients
Matthias Hoffmann et al.
AIDS (2007)
Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure
Pedram Sendi et al.
PLOS ONE (2007)
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Luigia Elzi et al.
CLINICAL INFECTIOUS DISEASES (2007)
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy
J. A. C. Sterne et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia
M Rotger et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: The swiss HIV cohort study
A Rauch et al.
CLINICAL INFECTIOUS DISEASES (2005)
Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
GM Clifford et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients:: a case-control study
C Felley et al.
AIDS (2004)
Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: Prospective multicentre study
C Zellweger et al.
AIDS (2004)
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival
C Staehelin et al.
AIDS (2003)
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
J Fellay et al.
LANCET (2001)
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy.
B Ledergerber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
G Greub et al.
LANCET (2000)
Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy.: The Swiss HIV Cohort Study
H Furrer et al.
AIDS (2000)
Share Paper
